Unlock measurable value at every stage of the clinical development and commercialization journey.
Recognizing AI and technology advancing pharma commercialization.
Inizio has won five awards at the PM360 Trailblazer Awards, recognizing the impact of its long-standing partnerships across AI innovation, pharma marketing, point-of-care engagement, and influential digital healthcare experiences.
From STEM AI – designed to strengthen pharmaceutical field team performance – to campaigns influencing screening behavior and patient engagement, the five wins demonstrate Inizio’s position as the global leader in Intelligent Commercialization™.
Here are the award-winning initiatives recognized at this year’s PM360 Trailblazer Awards across Inizio Ignite and Inizio Evoke.
Receiving Gold in the App/Digital Solution category, STEM AI is an AI-powered call recording and analysis solution that combines 18+ years of pharmaceutical benchmarking expertise with human insight to help field teams understand performance, uncover coaching opportunities, and turn HCP interactions into action.
Awarded Silver in the Consumer Website/Online Initiative category, the DETECT THE SOS™ website developed with Boehringer Ingelheim helped consumers connect kidney disease, cardiovascular risk, and early detection in a way that was understandable, memorable, and actionable. In Q1 alone, there were almost 60,000 visitors, spending an average of nearly four minutes on the site.
Cementing a double win in the Consumer Website/Online Initiative category, Inizio Evoke’s work with Novo Nordisk on Wegovy.com was awarded Gold. Since launch, the website had more than nine million visits, delivered a 73% year-on-year increase in traffic, and helped Wegovy become the #1 prescribed GLP-1 weight loss pill.
Signifying its second win of the night, DETECT THE SOS™ with Boehringer Ingelheim was awarded Silver in the Point of Care category.
With a goal of creating urgency around earlier CKD screening and diagnosis by activating both patients and HCPs, the initiative aimed to influence both sides of the exam-room conversation simultaneously. The program delivered 475,949,295 net impressions over a three-week period, driving significant increases in screening behavior.
Boehringer Ingelheim’s CKD Market Development Team – supported by Inizio Evoke – was awarded Gold for Marketing Team of the Year.
Bringing together combined expertise around one shared goal, the initiative has generated more than 1.4 billion impressions, reached 57.2 million people, and delivered a 19-point lift in testing intent.
Together, these five PM360 Trailblazer Awards highlight how Inizio and its partners are combining AI, data, creativity, and healthcare expertise to solve complex commercialization challenges and create meaningful impact across the patient and HCP journey.
Want to explore how Inizio can help you drive Intelligent Commercialization™ at every stage of the journey? Get in touch with our team to learn more.
Jump to a slide with the slide dots.
Elaine Ferguson explores how pharma leadership can support talent development, use AI to augment the workforce, and encourage continuous learning.
Read more
It's been an exciting two weeks at Inizio HQ as our London-based colleagues have officially moved into our new office in Farringdon.
Read more
Discover what drives oncology treatment choice when efficacy is similar, from safety and convenience to hidden trade-offs and patient burden.
Read more
The Directors of Inizio are pleased to present a mid-year update for 2026.
Read more
STEM AI wins Gold at the PM360 Trailblazer Awards, helping pharma field teams turn HCP conversations into actionable performance insights.
Read moreSign up to our mailing list to receive the latest thought leadership, downloads, and industry insights – straight to your inbox.
